ESCMID Consensus document for management of COVID-19 in immunocompromised patients

Key facts

Chair(s): Michele Bartoletti, Bologna, Italy and Roy Chemaly, Houston, United States

Approval date: May 2022

Expected completion: December 2024

Comment: Last status report date: 15.03.2024

Status Report

Guideline Development Steps

Status

Establishing Consensus Group Processes

Completed

Identifying Target Audience and Topic Selection

Completed

Consumer and Stakeholder Involvement

Completed

Conflict of Interest Considerations

Completed

Question Generation

Completed

Literature Searches

Completed

Screening of literature

Completed

Data Extraction

Ongoing

Summarising Evidence

Ongoing

Summarising Conclusions

Ongoing

Reporting

Not started

Public Consultation Phase

Not started

Submission to the Journal

Not started

Publication

Not started

Updating

Not started